Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?

Human Vaccines & Immunotherapeutics
Laure-Anne Van BellinghenNadia Demarteau

Abstract

Pertussis or whooping cough, a highly infectious respiratory infection, causes significant morbidity and mortality in infants. In adolescents and adults, pertussis presents with atypical symptoms often resulting in under-diagnosis and under-reporting, increasing the risk of transmission to more vulnerable groups. Maternal vaccination against pertussis protects mothers and newborns. This evaluation assessed the cost-effectiveness of adding maternal dTpa (reduced antigen diphtheria, Tetanus, acellular pertussis) vaccination to the 2016 nationally-funded pertussis program (DTPa [Diphtheria, Tetanus, acellular Pertussis] at 2, 4, 6, 18 months, 4 years and dTpa at 12-13 years) in Australia. A static cross-sectional population model was developed using a one-year period at steady-state. The model considered the total Australian population, stratified by age. Vaccine effectiveness against pertussis infection was assumed to be 92% in mothers and 91% in newborns, based on observational and case-control studies. The model included conservative assumptions around unreported cases. With 70% coverage, adding maternal vaccination to the existing pertussis program would prevent 8,847 pertussis cases, 422 outpatient cases, 146 hospitalizations...Continue Reading

References

Aug 11, 2000·The Medical Journal of Australia·P F ThomasB B Jalaludin
Aug 26, 2003·Archives of Disease in Childhood·N S CrowcroftE Miller
Mar 23, 2005·Health and Quality of Life Outcomes·Grace M LeeTracy A Lieu
May 7, 2005·The Pediatric Infectious Disease Journal·Edward Rothstein, Kathryn Edwards
Oct 14, 2005·The New England Journal of Medicine·Joel I WardUNKNOWN APERT Study Group
May 13, 2006·Epidemiology and Infection·M CagneyA Giammanco
Feb 14, 2007·American Journal of Preventive Medicine·Grace M LeeTracy A Lieu
Mar 28, 2008·PLoS Medicine·Joël MossongW John Edmunds
Jun 10, 2008·Vaccine·Grace M LeeCarl Heinz Wirsing von Konig
Aug 14, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jussi MertsolaJeanne-Marie Jacquet
Sep 3, 2010·The Pediatric Infectious Disease Journal·Alice Ruth FoxwellMark S Clements
Jan 31, 2012·PharmacoEconomics·Olivier Ethgen, Baudouin Standaert
May 19, 2012·Epidemiology and Infection·M F ClarkeH S Marshall
Jul 4, 2012·Vaccine·Mark H RozenbaumMaarten J Postma
Aug 8, 2013·The Medical Journal of Australia·Marlena C KaczmarekStephen B Lambert
Sep 11, 2013·PloS One·Lisa J McGarryMilton C Weinstein
Apr 8, 2014·The Medical Journal of Australia·Peter B McIntyre, Terence M Nolan
Oct 22, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gavin DabreraMary Ramsay
Nov 5, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·A TerlindenP Moore
Apr 26, 2016·The Journal of Infection·Albert Jan van HoekElizabeth Miller
Jul 1, 2016·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Lahn StraneyUNKNOWN Australian and New Zealand Intensive Care Society Centre for Outcomes and Resource Evaluation and the Australian and New Zea
Oct 6, 2016·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Sushena KrishnaswamyMichelle Giles
Nov 14, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gayatri AmirthalingamNick Andrews

❮ Previous
Next ❯

Methods Mentioned

BETA
PBAC

Software Mentioned

MS Excel

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.